# A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism

> **NCT01836562** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Chaitanya Hospital, Pune** · enrollment: 100 (estimated)

## Conditions studied

- Autism

## Interventions

- **BIOLOGICAL:** STEM CELL THERAPY

## Key facts

- **NCT ID:** NCT01836562
- **Lead sponsor:** Chaitanya Hospital, Pune
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01836562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01836562, "A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01836562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*